As it is shown in Fig. 5c, TNFSF4 expression in patients with B-ALL had a bimodal distribution with nearly 34% of B-ALL patients expressing relatively high levels of TNFSF4. Here, TNFSF4 is linked to precursor B-cell acute lymphoblastic leukemia.